Skip to content

Comparison of the Time to the First Rescue Analgesic Among Parturients Receiving Intrathecal Additive Fentanyl or Intrathecal Fentanyl With TAP Block or TAP Block Alone for Elective Cesarean Sections Under Hyperbaric Bupivacaine Spinal Anesthesia

Comparison of the Time to the First Rescue Analgesic Among Parturients Receiving Intrathecal Additive Fentanyl or Intrathecal Fentanyl With TAP Block or TAP Block Alone for Elective Cesarean Sections Under Hyperbaric Bupivacaine Spinal Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05550597
Enrollment
93
Registered
2022-09-22
Start date
2022-08-15
Completion date
2023-03-15
Last updated
2023-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Cesarean Section

Brief summary

The postoperative pain management after cesarean section under spinal anestheisa is done using various modalities. The commonly used regimens are systemic NSAIDs/Opioids, USG guided TAP block or Intrathecal additive Fentanyl or combined intrathecal fentanyl and USG guided TAP block. Investigators aim to compare the postoperative analgesia in terms of time to the first rescue analgesic in parturients receiving intrathecal additive fentanyl only, or intrathecal fentanyl with USG guided TAP block or USG guided TAP block alone for elective CS done under hyperbaric bupivacaine spinal anesthesia.

Detailed description

Investigators will enroll 93 parturients planned for elective CS under hyperbaric bupivacaine spinal anesthesia and allocate them into three groups comprising intrathecal additive fentanyl only, or intrathecal fentanyl with USG guided TAP block or USG guided TAP block alone. The primary outcome will be time to the first rescue analgesics.

Interventions

Intrathecal additive Fentanyl with Hyperbaric Bupivacaine during Spinal Anesthesia

Intrathecal additive Fentanyl with Hyperbaric Bupivacaine during Spinal Anesthesia Ultrasound-guided Transversus Abdominal plane block using Bupivacaine 0.25% Injectable Solution

Sponsors

Nepal Mediciti Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiology(ASA) physical status II * Able to read and understand the information sheet and to sign and date the consent form * Scheduled for elective CS planned with Spinal anesthesia * Gestational age \> 37 weeks and \< weeks assessed on the dating scale.

Exclusion criteria

* Complicated pregnancy; defined as having preeclampsia or placenta accreta,increta and percreta * Opioid addiction or dependence * Contraindications to TAP block( Ski infection, abdominal wall muscle defects) * Allergy to any medications used in the study * Case converted to General Anesthesia * Cases who develop postoperative hemorrhage, amniotic fluid embolism

Design outcomes

Primary

MeasureTime frameDescription
To compare the time to the first rescue analgesicsTime to first complain of pain with Numeric Rating scale(NRS) greater than or equal to 4 within first 24 hoursThe time from the arrival to Postoperative care Unit to first complain of pain with Numeric Rating scale(NRS) greater than or equal to 4 among the Parturients Receiving Intrathecal Additive Fentanyl or Intrathecal Fentanyl With TAP Block or TAP Block Alone for Elective Cesarean Sections Under Hyperbaric Bupivacaine Spinal Anesthesia

Secondary

MeasureTime frameDescription
Percentage of participants with treatment related side effects like pruritus, nausea and vomiting.Time to first complain of pain with Numeric Rating scale(NRS) greater than or equal to 4 within first 24 hoursTo compare the side effects like pruritus, nausea and vomiting Among Parturients among the Parturients Receiving Intrathecal Additive Fentanyl or Intrathecal Fentanyl With TAP Block or TAP Block Alone for Elective Cesarean Sections Under Hyperbaric Bupivacaine Spinal Anesthesia

Countries

Nepal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026